Statistics

Total Visits

Views
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer11

Select a period of time:

Number of views in the range

Views
Phase II randomized, double-blind, placebo-controlled study of AMG 386 (trebananib) in combination with cisplatin and capecitabine in patients with metastatic gastro-oesophageal cancer6

Views

Views
November 20230
December 20230
January 20242
February 20241
March 20241
April 20240
May 20242
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States6
 

Top cities views

Views
Ashburn2
Boardman1